Argos TherapeuticsARGSQ
13F holders, Q4 2025 (December 31)1holders
$0.00avg. 13F price*
At the end of Q4 2025, 1 institutions reported holding Argos Therapeutics Inc. (ARGSQ) in their 13F filings. The largest holder was Motiv8 Investments LLC ($0).
- Company
- Argos Therapeutics Inc.
- CUSIP
- 040221202
- Latest filing quarter
- Q4 2025
Total Exit/New Position Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| Motiv8 Investments LLC | 0.00% | New | 40 | $0 |
"% of holder's portfolio" is ARGSQ's weight in each manager's 13F, not the share of Argos Therapeutics Inc. the manager owns.